Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024;37(123):2-5.
Epub 2024 Oct 2.

Managing ocular allergy

Affiliations

Managing ocular allergy

Anahita Kate et al. Community Eye Health. 2024.
No abstract available

PubMed Disclaimer

Figures

Figure 1
Figure 1
Red eyes (hyperaemia and limbal pigmentation)
Figure 2
Figure 2
Mild, blister-like swelling of the conjunctiva (chemosis)
Figure 3
Figure 3
Slit lamp image showing small papillae in the upper eyelid. This patient has perennial allergic conjunctivitis.
Figure 4
Figure 4
Large papillae, with a typical ‘cobble-stone’ appearance, in a patient with vernal keratoconjunctivitis.
Figure 5
Figure 5
Limbal thickening due to inflammation. The small inflammatory nodules are known as Horner-Trantas dots.
Figure 6
Figure 6
Shield ulcer in the upper part of the cornea.
None
None

References

    1. Ali A, Bielory L, Dotchin S, Hamel P, Strube YNJ, Koo EB. Management of vernal keratoconjunctivitis: Navigating a changing treatment landscape. Surv Ophthalmol. 2023;S0039-6257(23)00138-8. - PubMed
    1. Leonardi A, Silva D, Perez Formigo D, Bozkurt B, Sharma V, Allegri P, et al. . Management of ocular allergy. Allergy. 2019;74(9):1611-30. - PubMed
    1. Castillo M, Scott NW, Mustafa MZ, Mustafa MS, Azuara-Blanco A. Topical antihistamines and mast cell stabilisers for treating seasonal and perennial allergic conjunctivitis. Cochrane Database Syst Rev. 2015;2015(6):CD009566. - PMC - PubMed
    1. Labcharoenwongs P, Jirapongsananuruk O, Visitsunthorn N, Kosrirukvongs P, Saengin P, Vichyanond P. A double-masked comparison of 0.1% tacrolimus ointment and 2% cyclosporine eye drops in the treatment of vernal keratoconjunctivitis in children. Asian Pac J Allergy Immunol. 2012;30(3):177-84. - PubMed
    1. Kumari R, Saha BC, Sinha BP, Mohan N. Tacrolimus versus Cyclosporine-Comparative Evaluation as First line drug in Vernal keratoconjuctivitis. Nepal J Ophthalmol. 2017;9(18):128-35. - PubMed

LinkOut - more resources